If looking to use a GLP-1 for help with weight loss, you will start with what is essentially a micro-dose: you start on the lowest .25mg dose of semaglutide and then gradually increase the dosing as tolerated, and as needed, as long as it dovetails with your weight loss goals
Recent diabetes guidelines and recommendations have moved toward a more individualized and CV risk-focused approach for managing patients with T2DM
Recent studies highlight the increased risk for gastrointestinal issues when taking a GLP-1 receptor agonist like Mounjaro
[DOI] [PubMed] [Google Scholar] 257.Lin P.Y., Chen K.H., Miao Y.B., Chen H.L., Lin K.J., Chen C.T., Yeh C.-N., Chang Y., Sung H.-W
En 1996, se descubri que el GLP-1 administrado directamente en el cerebro de roedores reduca su ingesta de alimentos
However, emerging evidence suggests that stopping therapy often leads to weight regain, reinforcing the concept of obesity as a chronic condition requiring ongoing pharmacologic support